The Joint Corp. (JYNT)

NASDAQ: JYNT · USD

$7.23

+0.02 (+0.2%)· Recorded snapshot

Market cap	98.4M
Revenue (ttm)	58.5M
Net income (ttm)	3.8M
EPS (ttm)	$0.26
Shares out	13.6M
P/E (trailing)	27.8x
P/E (forward)	12.8x
Volume	30,653
Beta	1.09

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 58.5M
Net income (ttm): 3.8M
EPS (ttm): $0.26
P/E (trailing): 27.8x
P/E (forward): 12.8x
Market cap: 98.4M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Manter

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E12.8

P25 n/aP50 n/aP75 n/a

Trailing P/E27.8

P25 n/aP50 n/aP75 n/a

ROE10.6

P25 n/aP50 n/aP75 n/a

ROIC6.7

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All JYNT indicators

Market & fundamental data

Available fields

254

Groups with data

Currency

USD

Showing 254 of 254 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001612630
Company name	The Joint Corp.
Country	United States
Country code	US
CUSIP number	47973J102
Earnings date	2026-11-05
Earnings time	amc
Employees	330
Employees change	-406
Employees growth	-55.16%
Enterprise value	$78.2M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2010
Industry	Medical Care Facilities
IPO date	2014-11-11
Is primary listing	Yes
Is SPAC	No
ISIN number	US47973J1025
Last 10-K release date	2026-03-13
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$98.4M
Market cap category	Micro-Cap
Next earnings date	2026-11-05
Options	Yes
Price	$7.23
Price currency	USD
Sector	Healthcare
SIC code	6794
Stock price date	2026-10-28
Symbol	JYNT
U.S. state	Arizona
Website	https://www.thejoint.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	27.75x
Average P/E ratio (5Y)	124.08x
Earnings yield	3.6%
EV/Earnings	20.42x
EV/EBIT	33.41x
EV/EBITDA	19.29x
EV/FCF	18.34x
EV/Sales	1.32x
FCF / EV yield	5.45%
FCF yield	4.33%
Forward EV/Sales	1.25x
Forward P/E	12.84x
Forward P/S	1.58x
Graham number	2.60489
Graham upside	-63.72%
Industry forward P/E	14.81x
Industry P/E	18.21x
Lynch fair value	$1.30
Lynch upside	-81.9%
P/(FCF - SBC) ratio	34.24x
P/(OCF - SBC) ratio	24.36x
P/B ratio	6.22x
P/E ratio	27.82x
P/FCF ratio	23.1x
P/OCF ratio	18.14x
P/S ratio	1.67x
Price / tangible book value	6.16x
Price/EBITDA ratio	24.29x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	3.97%
EBITDA margin	6.87%
Effective tax rate	1.61%
FCF margin	7.22%
Gross margin	81.76%
Operating margin	3.97%
Pretax margin	3.61%
Profit margin	6.49%
Profit per employee	$11,510
Profitable quarters	7
Profitable years	1
Revenue per employee	$177,424
ROA	2.33%
ROA (5Y)	0.79%
ROCE	8.4%
ROE	10.62%
ROE (5Y)	-2.95%
ROIC	6.7%
SBC / revenue	2.35%
Tax / revenue	0.06%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth (Q)	652.62%
EPS growth (QoQ)	-49.96%
EPS growth 3Y	4.48%
EPS growth 5Y	-26%
EPS growth quarters	5
EPS growth years	2
FCF growth	25.05%
FCF growth (Q)	432.43%
FCF growth 3Y	-28.72%
FCF growth 5Y	-19.81%
Gross profit growth	14.05%
Gross profit growth (Q)	21.02%
Gross profit growth 3Y	-22.25%
Gross profit growth 5Y	-5.27%
Net income growth (Q)	599.44%
Net income growth (QoQ)	-49.73%
Net income growth 3Y	2.76%
Net income growth 5Y	-26.1%
Net income growth quarters	7
Net income growth years	2
OCF growth	13.49%
OCF growth (Q)	152.37%
OCF growth 3Y	-32.01%
OCF growth 5Y	-20.69%
Operating income growth 3Y	11.08%
Operating income growth 5Y	-22.88%
Revenue growth	9%
Revenue growth (Q)	14.41%
Revenue growth (QoQ)	2.44%
Revenue growth 10Y	13.07%
Revenue growth 3Y	-19.38%
Revenue growth 5Y	-3.57%
Revenue growth quarters	7
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-1.2M
Depreciation and amortization	$1.7M
EBIT	$2.3M
EBITDA	$4M
EPS	$0.26
FCF per share	$0.31
Financing cash flow	$-12.6M
Free cash flow	$4.2M
Free cash flow minus SBC	$2.9M
Gross profit	$47.9M
Income taxes	$34,079
Investing cash flow	$2,186
Net cash flow	$-7.2M
Net income	$3.8M
Operating cash flow minus SBC	$4M
Operating income	$2.3M
Revenue	$58.5M
Stock-based compensation	$1.4M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	3.43
Book value per share	$1.16
Debt / EBITDA	0.46
Debt / equity	0.13
Debt / FCF	0.48
Interest coverage	1,532.63
Long-term assets	$7.8M
Long-term liabilities	$11.8M
Net cash (debt)	$20.1M
Net cash / market cap	20.6%
Net cash growth	-27.21%
Net debt / EBITDA	-5
Net debt / equity	-1.27
Net debt / FCF	-4.76
Piotroski F-Score	7
Property, plant and equipment	$4.3M
Shareholders' equity	$15.9M
Tangible book value	$15.9M
Tangible book value per share	$1.16
Total assets	$51.6M
Total cash	$22.2M
Total debt	$2M
Total liabilities	$35.8M
WACC	10.05%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.94
Current assets	$43.8M
Current liabilities	$24M
Current ratio	1.83
Net working capital	$-2M
Quick ratio	1.02
Working capital	$19.8M
Working capital turnover	2.44

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	3.17%
Dividend yield	0%
Shareholder yield	3.17%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	183.53%
10Y return CAGR	10.99%
10Y total return	183.53%
150-day SMA	$8.44
1D price change	0.21%
1M price change	-12.15%
1M total return	-12.15%
1W price change	0.56%
1W total return	0.56%
1Y price change	-13.62%
1Y return CAGR	-13.63%
1Y total return	-13.62%
20-day SMA	$7.16
200-day SMA	$8.62
3M price change	-15.64%
3M total return	-15.64%
3Y price change	-8.37%
3Y return CAGR	-2.87%
3Y total return	-8.37%
50-day SMA	$7.83
50-day SMA vs 200-day SMA	50under200
52-week high	$10.67
52-week high date	2026-01-16
52-week low	$6.79
52-week low date	2026-10-14
5Y price change	-90.99%
5Y return CAGR	-38.21%
5Y total return	-90.99%
6M price change	-20.37%
6M total return	-20.37%
All-time high	$111.06
All-time high date	2021-09-07
All-time low	$1.85
All-time low date	2016-07-01
Average true range (ATR)	$0.23
Average volume	66K
Beta (1Y)	0.9
Beta (2Y)	1.06
Beta (5Y)	1.09
Change from 52-week high	-32.24%
Change from 52-week low	6.48%
Change from all-time high	-93.49%
Change from all-time low	290.81%
Change from open	0.56%
Day's gap	-0.42%
Dollar volume	$221,621
High price	$7.29
Low price	$7.16
Monthly RSI	35.74
Open price	$7.19
Position in 52-week range	53.85%
Previous close	$7.22
Price vs 150-day SMA	-14.38%
Price vs 20-day SMA	1.05%
Price vs 200-day SMA	-16.12%
Price vs 50-day SMA	-7.63%
Relative volume	0.46
RSI	43.35
Sharpe ratio	-0.35
Sharpe ratio (3Y)	0.07
Sharpe ratio (5Y)	-0.65
Sortino ratio	-0.33
Sortino ratio (3Y)	0.25
Sortino ratio (5Y)	-0.82
Volume	30.7K
Weekly RSI	38.27
YTD price change	-17.09%
YTD total return	-17.09%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	6.5M
Float percentage	47.62%
Shares change (QoQ)	0.44%
Shares change (YoY)	-3.17%
Shares held by insiders	16.48%
Shares held by institutions	35.63%
Shares outstanding	13.6M
Short % of float	6.26%
Short % of shares	2.98%
Short ratio	4.4 days

Deeper analysis on JYNT

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this JYNT report

Is a complete JYNT research report available?

No complete published report is available for The Joint Corp. (JYNT) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

The Joint Corp. (JYNT)

Price

Financial snapshot

Fair-value bridge

Latest news · JYNT

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All JYNT indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on JYNT

Frequently asked questions